Scholars Central

Short communicationPublished 24 Aug 2023

RNA editing and the epitranscriptome in heart failure

Authors: Jacek Kubica

Current Trends in Cardiology

Volume 7 · Issue 8 · Pages 1–2

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The arising utilization of immunotherapies in disease treatment builds the gamble of immunotherapy-related cardio toxicity. Rather than regular chemotherapy, these original treatments have extended the structures and introductions of cardiovascular harm to a wide range from asymptomatic changes to fulminant short-and long haul difficulties concerning cardiomyopathy, arrhythmia, and vascular illness. In disease patients and, especially, malignant growth patients going through (resistant) treatment, cardio-oncological observing is a mind boggling exchange between pretherapeutic risk evaluation, recognizable proof of looming cardio toxicity, and post-remedial observation. For these reasons, the cardio-oncologist can return to a wide range of atomic cardio logical demonstrative workup.

Subjects

Cardiology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Current Trends in Cardiology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalCurrent Trends in Cardiology
  • SubjectCardiology
  • BylineArticles whose byline prints “Jacek Kubica”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels